DRUMMOND, DARYL C.,KIRPOTIN, DMITRI B.,KAMOUN, WALID
申请号：
CA3016333
公开号：
CA3016333A1
申请日:
2017.03.16
申请国别(地区):
CA
年份:
2017
代理人:
摘要：
EphA2 targeted doxorubicin generating nano-liposomes are useful in the treatment of EphA2 positive cancer comprising cancer cells expressing over about 3000 EphA2 receptors/cell. Diagnostic methods for identifying EphA2 positive cancer patients and methods of treating identified patients with a Eph-A2 targeted nanoliposome encapsulating a docetaxel prodrug are provided.
